Doppler-detected tricuspid, mitral or aortic regurgitation in end-stage renal disease

Bryg, Robert J.; Gordon, Pamela R.; Migdal, Stephen D.

doi:10.1016/0002-9149(89)90266-x

Cited by 18 publications

(7 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of aortic valve calcification is higher in patients with CKD than in the general population and dialysis has been proposed to be an independent risk factor for aortic valve calcification [1,2,3,4,5,6,7,8,9]. Different studies on SAVR in dialysis patients have been performed [16,17,18], showing an increased surgical risk in these patients.…”

Section: Discussionmentioning

confidence: 99%

“…One potential reason might be the faster progression rate of cardiac valvular calcification in patients with ESRD compared to the normal population [1,2,3,4,5,6,7,8,9]. The higher EuroSCORE reflects the poor preinterventional clinical status of these patients, making them not suitable for open surgery.…”

Section: Discussionmentioning

confidence: 99%

“…In patients on chronic hemodialysis, aortic valve calcification is present in 25–55% and it occurs 10–20 years earlier than in the general population [1,2,3,4,5,6,7,8,9]. Pathophysiology and the rate of progression of cardiac valvular calcification in patients with ESRD appear to be different from those in the general population, with secondary hyperparathyroidism being one of the most important predisposing factors.…”

Section: Background/aimsmentioning

confidence: 99%

See 2 more Smart Citations

Transcatheter Aortic Valve Implantation in Dialysis Patients

Rau¹,

Lange

Kupatt

et al. 2012

Nephron Clin Pract

View full text Add to dashboard Cite

Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies. The aim of this study is to compare the outcomes of TAVI for dialysis patients with those for patients with chronic kidney disease (CKD) stages 3 and 4 and to compare TAVI with open surgery in dialysis patients. Methods: Part I: comparison of 10 patients on chronic hemodialysis with 116 patients with non-dialysis-dependent CKD undergoing TAVI. Part II: comparison of transcatheter (n = 15) with open surgical (n = 24) aortic valve replacement in dialysis patients. Results: Part I: dialysis patients were significantly younger (72.3 vs. 82.0 years; p < 0.01). Hospital stay was significantly longer in dialysis patients (21.8 vs. 12.1 days; p = 0.01). Overall 30-day mortality was 3.17%, with no deaths among dialysis patients. Six-month survival rates were similar (log-rank p = 0.935). Part II: patient age was comparable (66.5 vs. 69.5 years; p = 0.42). Patients in the surgical group tended to stay longer in hospital than TAVI patients (29.5 vs. 22.5 days; p = 0.35). Conclusion: TAVI is a safe procedure in patients on chronic hemodialysis. Until new data become available, we find no compelling reason to refuse these patients TAVI.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Background/aimsmentioning

confidence: 99%

See 1 more Smart Citation

Transcatheter Aortic Valve Implantation in Dialysis Patients

Rau¹,

Lange

Kupatt

et al. 2012

Nephron Clin Pract

View full text Add to dashboard Cite

show abstract

“…Mitral annular calcification was present in 35% of the patients. Aortic calcification, which is often associated with aortic stenosis or regurgitation, is also not uncommon [40,41]. The underlying basis for valve disease in chronic kidney disease, like the basis of the unusually high prevalence of coronary artery disease, is not well understood.…”

Section: Vhd Etiologymentioning

confidence: 99%

Etiology of Valvular Heart Disease in the 21st Century

Boudoulas

Borer²,

Boudoulas

2013

Cardiology

View full text Add to dashboard Cite

show abstract

“…Patients with ESRD on chronic dialysis are at an increased risk of valvular heart disease and aortic calcification . Until recently, surgical aortic valve replacement has been the only option in patients with symptomatic aortic stenosis on chronic dialysis.…”

Section: Discussionmentioning

confidence: 99%

Reversal of end stage renal disease in patient with transcatheter aortic valve replacement

Damluji

Bilsker

Cohen

2013

Cathet Cardio Intervent

View full text Add to dashboard Cite

Transcatheter aortic valve replacement (TAVR) has become an alternative intervention in high-risk and inoperable patients with symptomatic aortic valve stenosis. The procedure has been associated with favorable clinical outcomes and safety profile in patients with end stage renal disease (ESRD). We describe a case of improved kidney function in a patient with ESRD without further need for dialysis after TAVR.

show abstract

Doppler-detected tricuspid, mitral or aortic regurgitation in end-stage renal disease

Cited by 18 publications

References 10 publications

Transcatheter Aortic Valve Implantation in Dialysis Patients

Transcatheter Aortic Valve Implantation in Dialysis Patients

Etiology of Valvular Heart Disease in the 21st Century

Reversal of end stage renal disease in patient with transcatheter aortic valve replacement

Contact Info

Product

Resources

About